Skip to content

Batch information on every product pageTHC < 0.3%Shipped from France10% off when you sign up

AM-1220

A synthetic CB1 agonist, Ki of 2.4 nM at human CB1. Harm reduction, not a product.

Level of detail

Harm-reduction warning

No characterised human dose: animal / in vitro data only. Effect profile, safety margin and acute toxicity are not documented in human clinical practice. Extremely potent compound: severe effects, seizures and deaths reported in the literature.

C₂₆H₂₆N₂O

CAS 137642-54-7

Family
Synthetic CB receptor agonistNew psychoactive substance
Molar mass
382.50 g/mol

Updated on

In plain terms

AM-1220 is not a hemp cannabinoid: it is a laboratory molecule, described in 1996 by pharmaceutical chemists, which binds to the same receptors as THC, with a stronger affinity in the published assays. It was identified in 2012 in products sold online and in Japan, then in dried plants onto which it had been sprayed, sold as "legal herb", often under another label. It is not a consumer product: no clinical study has evaluated its effects or its safety in human beings.

Receptors and activity

Target network

CB1AgonistKi = 2.4 nM · human[3H]CP55,940 displacement, recombinant human CB1; EC50 44.4 nM in [35S]GTPγS (Emax 131.5%)
  • Activates
  • Binds or modulates

The lower the cited value, the closer the target sits to AM-1220: one ring per factor of 100. A target with no measured value stays on the edge.

Where these targets live

Where each target has been found in humans, according to the cited studies. The map shows the target, not an effect of AM-1220.

Brain, side view
Body, front view
Blood

CB1CB1 found in 7 regions of the body

  1. Basal gangliadenseMost dense in basal ganglia outflow nuclei1
  2. CerebellumdenseVery dense in the cerebellum1
  3. HippocampusdenseVery high concentrations in the hippocampus2
  4. AmygdaladenseHigh concentrations in the amygdala2
  5. CortexpresentPresent throughout the neocortex2
  6. Adipose tissuepresentExpressed in adipose tissue3
  7. GutpresentColonic epithelium, smooth muscle and plexus4

Cited values

  1. CB1AgonistKi = 2.4 nM · human77 out of 100

    Marusich et al. 2018, Neuropharmacology (new tab) · [3H]CP55,940 displacement, recombinant human CB1; EC50 44.4 nM in [35S]GTPγS (Emax 131.5%)

  2. CB2Binding (function not established)Ki = 0.3 nM · human93 out of 100

    Marusich et al. 2018, Neuropharmacology (new tab) · [3H]CP55,940 displacement, recombinant human CB2; [35S]GTPγS stimulation not determinable

  3. TRPV1Agonistno measured value cited

    Significant activation of the TRPV1 channel at a concentration producing the maximal effect at CB1; one of only three synthetic agonists tested in this case (Andersen et al., Eur J Pharmacol 2021); no EC50 value published

Bar length follows the measured value (Ki, Kd, EC50 or IC50), on one scale shared by every entry, from 100 µM to 0.1 nM. A target with no cited value has no bar.

Pharmacology

AM-1220 belongs to the aminoalkylindoles, naphthoylindole subfamily: an indole nucleus bearing a naphthalene-1-carbonyl group at position 3 and a (1-methylpiperidin-2-yl)methyl group on the nitrogen. Marusich et al. (Neuropharmacology 2018) measure an affinity Ki = 2.40 nM at the human CB1 receptor, with an EC50 of 44.4 nM in stimulation of [35S]GTPγS; Δ9-THC appears there with a Ki of 40.7 nM, a value from Showalter et al. (1996) reproduced in the table, a ratio of about seventeen. In mice, AM-1220 fully substitutes for THC in drug discrimination, with a median effective dose of 0.26 µmol/kg against 4.96 µmol/kg for THC, a potency about nineteen times higher. In the same [35S]GTPγS assay, its maximal response at CB1 (131.5%) is lower than that of the reference CP55,940 (163.3%): the study therefore does not allow the molecule to be classed as a partial or full agonist. The CB2 profile is atypical: sub-nanomolar affinity (Ki = 0.26 nM) without measurable stimulation of [35S]GTPγS through CB2. Andersen et al. (Eur J Pharmacol 2021) add a target outside the cannabinoid system: at a concentration maximal for CB1, AM-1220 is one of only three synthetic agonists tested to significantly activate the TRPV1 channel. Beyond these in vitro measurements and the animal model, human data are lacking: no controlled study, no pharmacokinetics in volunteers, and the only forensic case published that we found associates AM-1220 with two other synthetic agonists (MAM-2201 and AM-2232), which rules out attributing causality to it alone.

Key sources.

History

Source
Laboratory. No natural occurrence: a molecule arising from pharmaceutical research, diverted to the market for smokable herbal mixtures, where it is sprayed onto dried plant material sold under fanciful names. It was identified in 2012 in a « research chemical » bought online and in illegal products in Japan (Kneisel et al., 2012; Uchiyama et al., 2012), then in German herbal mixtures analysed in the autumn of 2012 (Langer et al., 2014).

Origin

Laboratory synthesis

No biosynthetic pathway: AM-1220 exists neither in hemp nor in any living organism. It is obtained by wholly synthetic means, within the aminoalkylindole chemical class. Described here by chemical class only.

Classification

Family, origin and source verification

Family

Synthetic CB receptor agonist › New psychoactive substance

Class

naphthoylindole

Verification

Classification, sources and binding values checked on 20 October 2026; text read against its sources and Wikipedia.

Wikipedia (English)

AM-1220 (new tab)

Article paired by the molecule's structure (InChIKey), revision read on 19 October 2026. Read as a second opinion, never cited as a source.

References

  1. Marusich JA et al., Finding order in chemical chaos: continuing characterization of synthetic cannabinoid receptor agonists, Neuropharmacology 2018: CB1/CB2 affinity, [35S]GTPγS and THC substitution for AM-1220 (new tab)PMID 29113898
  2. Andersen HK et al., Molecular signaling of synthetic cannabinoids: comparison of CB1 receptor and TRPV1 channel activation, Eur J Pharmacol 2021: activation of the TRPV1 channel by AM-1220 (new tab)PMID 34224700
  3. Watanabe S, Kuzhiumparambil U, Fu S, Forensic Toxicol 2018: in vitro metabolism of AM1220 (human liver microsomes, Cunninghamella elegans) (new tab)PMID 29963209
  4. Zaitsu K et al., Int J Legal Med 2015 (erratum 2016, PMID 26718839): determination by LC/Q-TOFMS of MAM-2201, AM-1220 and AM-2232 in post-mortem plasma and urine (new tab)PMID 26349566
  5. Deng H et al., J Med Chem 2005: cannabinergic indole analogues (AM-2233 series); values for AM-1220 at rat CB1 and mouse CB2 read in ChEMBL (new tab)PMID 16190764
  6. Langer N et al., Drug Test Anal 2014: identification and quantification of synthetic agonists in « spice »-type mixtures in Germany (autumn 2012) (new tab)PMID 23723183
  7. D'Ambra TE et al., C-Attached aminoalkylindoles: potent cannabinoid mimetics, Bioorg Med Chem Lett 1996;6:17-22 (new tab)DOI 10.1016/0960-894X(95)00560-G
  8. Kneisel S et al., Identification of the cannabimimetic AM-1220 and its azepane isomer in a research chemical and several herbal mixtures, Forensic Toxicol 2012;30:126-134 (new tab)DOI 10.1007/s11419-012-0137-6
  9. Uchiyama N et al., Identification of two new-type synthetic cannabinoids (APICA, APINACA) and detection of five synthetic cannabinoids, including AM-1220 and AM-1248, in illegal products, Forensic Toxicol 2012;30:114-125 (new tab)DOI 10.1007/s11419-012-0136-7
  10. ANSM, consolidated list of substances classified as narcotics, updated 16 February 2026 (annex IV, « indol-3-yl methanone » family, AM-1220 cited as an example) (new tab)
  11. Order of 31 March 2017 amending the order of 22 February 1990: « indol-3-yl methanone » family of annex IV (Légifrance, JORF of 6 April 2017) (new tab)
  12. INCB, Green List of psychotropic substances under international control, 36th edition, 2025: AM-1220 is not listed (AM-2201 and JWH-018 are) (new tab)
  13. ChEMBL CHEMBL68641 (AM-1220): measured activities and source publications (new tab)

Identifiers

Names

IUPAC name
[1-[(1-methylpiperidin-2-yl)methyl]indol-3-yl]-naphthalen-1-ylmethanone
Other names
AM1220 · AM 1220 · (±)-AM-1220 · CHEMBL68641

Identifiers

Formula
C₂₆H₂₆N₂O
CAS
137642-54-7
PubChem CID
9929889(new tab)
InChIKey
URKVBEKZCMUTQC-UHFFFAOYSA-N
SMILES
CN1CCCCC1CN2C=C(C3=CC=CC=C32)C(=O)C4=CC=CC5=CC=CC=C54

Machine-readable entry (JSON)

LLM ingestion format: a structured superset of the entry (identifiers, binding, versioned legal status). Full corpus.